DE3587154D1 - Immunoaerztliche verfahren und zusammensetzungen unter verwendung von gegen maligne neoplasmen spezifischen antigenen. - Google Patents

Immunoaerztliche verfahren und zusammensetzungen unter verwendung von gegen maligne neoplasmen spezifischen antigenen.

Info

Publication number
DE3587154D1
DE3587154D1 DE8686900697T DE3587154T DE3587154D1 DE 3587154 D1 DE3587154 D1 DE 3587154D1 DE 8686900697 T DE8686900697 T DE 8686900697T DE 3587154 T DE3587154 T DE 3587154T DE 3587154 D1 DE3587154 D1 DE 3587154D1
Authority
DE
Germany
Prior art keywords
maligne
neoplasms
immuno
compositions
medical procedures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686900697T
Other languages
English (en)
Other versions
DE3587154T2 (de
Inventor
John Mcmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3587154D1 publication Critical patent/DE3587154D1/de
Publication of DE3587154T2 publication Critical patent/DE3587154T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8686900697T 1985-01-18 1985-12-20 Immunoaerztliche verfahren und zusammensetzungen unter verwendung von gegen maligne neoplasmen spezifischen antigenen. Expired - Fee Related DE3587154T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/692,822 US4692332A (en) 1985-01-18 1985-01-18 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
PCT/US1985/002556 WO1986004241A1 (en) 1985-01-18 1985-12-20 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms

Publications (2)

Publication Number Publication Date
DE3587154D1 true DE3587154D1 (de) 1993-04-08
DE3587154T2 DE3587154T2 (de) 1993-06-09

Family

ID=24782166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686900697T Expired - Fee Related DE3587154T2 (de) 1985-01-18 1985-12-20 Immunoaerztliche verfahren und zusammensetzungen unter verwendung von gegen maligne neoplasmen spezifischen antigenen.

Country Status (6)

Country Link
US (2) US4692332A (de)
EP (1) EP0211013B1 (de)
JP (2) JPH0774159B2 (de)
CA (1) CA1271136A (de)
DE (1) DE3587154T2 (de)
WO (1) WO1986004241A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851395A (en) * 1976-07-07 1989-07-25 Kureha Kagaku Kogyo Kabushiki Kausha Nitrogen-containing polysaccharide
US4883662A (en) * 1984-04-10 1989-11-28 Clinical Biotechnologies, Inc. Method of increasing natural killer cell population of cancer patients
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4970071A (en) * 1985-01-18 1990-11-13 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
US4849402A (en) * 1986-10-03 1989-07-18 Decatur-Frp/Partners Therapeutic treatment of abnormal cell growth with follicle regulatory protein
DE3751602T2 (de) * 1987-05-12 1996-05-02 Serono Pharm Praep Subkutane Verabreichung des humanen Choriongonadotropins.
US4966753A (en) * 1987-08-18 1990-10-30 Molecular Rx, Inc. Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
EP0472467A3 (en) * 1990-08-20 1993-03-17 Chiba Flour Milling Co. Ltd. Lps-containing analgesics and veterinary analgesics
US5965528A (en) * 1991-09-27 1999-10-12 Mcgill University Recombinant human alph-fetoprotein as an immunosuppressive agent
US6331611B1 (en) 1991-09-27 2001-12-18 Mcgill University Expression and purification of cloned human alpha-fetoprotein
US6288034B1 (en) * 1995-01-24 2001-09-11 Martinex R & D Inc. Recombinant human alpha-fetoprotein as an immunosuppressive agent
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5851997A (en) * 1994-10-04 1998-12-22 Harris; Pamela Jo Use of human chorionic gonadotropin as an immune-potentiating antiviral agent
US5700781A (en) * 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
US7101837B1 (en) 1995-01-24 2006-09-05 Martinex R & D Inc. Recombinant human alpha-fetoprotein as a cell proliferative agent
US6534479B1 (en) 1995-01-24 2003-03-18 Martinex R & D Inc. Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers
US5610136A (en) * 1996-01-30 1997-03-11 Milkhaus Laboratory, Inc. Method for treatment of benign prostatic hypertrophy
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
US5877198A (en) * 1996-10-17 1999-03-02 Milkhaus Laboratory, Inc. Treatment of urinary incontinence
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US7101847B2 (en) * 2002-10-11 2006-09-05 Milkhaus Laboratory, Inc. Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
WO2007035395A2 (en) * 2005-09-16 2007-03-29 Virginia Commonwealth University Intellectual Property Foundation Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors
US20100304873A1 (en) * 2009-05-28 2010-12-02 Lipa Markowitz Bowling Ball and Football Game Controller
ITMI20120910A1 (it) 2012-05-25 2013-11-26 Menfi Ind S P A Utensile di riscaldamento

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2310937A (en) * 1935-05-02 1943-02-16 Canadian American Pharmaceutic Pain-alleviating material
US3269913A (en) * 1962-05-11 1966-08-30 Parke Davis & Co Staphylococcal-immunizing products and methods for their production
FR6513M (de) * 1967-07-12 1968-12-02
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
US4285930A (en) * 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4410510A (en) * 1980-03-10 1983-10-18 Virginia Livingston-Wheeler Method for preparing a purified extraction residue fraction and its use in stimulating the immune response
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4521405A (en) * 1982-05-17 1985-06-04 John McMichael Methods and materials for treatment of disease states involving immunological factors
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia

Also Published As

Publication number Publication date
JPH07309775A (ja) 1995-11-28
JPH0774159B2 (ja) 1995-08-09
DE3587154T2 (de) 1993-06-09
JP2534027B2 (ja) 1996-09-11
US4692332A (en) 1987-09-08
JPS62501772A (ja) 1987-07-16
US4877610A (en) 1989-10-31
WO1986004241A1 (en) 1986-07-31
EP0211013A4 (de) 1988-08-04
EP0211013B1 (de) 1993-03-03
CA1271136A (en) 1990-07-03
EP0211013A1 (de) 1987-02-25

Similar Documents

Publication Publication Date Title
DE3587154D1 (de) Immunoaerztliche verfahren und zusammensetzungen unter verwendung von gegen maligne neoplasmen spezifischen antigenen.
DK268586A (da) Haarfrisure-moussesammensaetning
KR880700844A (ko) 엘라스토머- 플라스틱 혼합물
DK354886A (da) Mikroemulsionsmidler
BR8700056A (pt) Composicao organopolisiloxano
DK398887A (da) Antistoffer
FR2580402B1 (fr) Permeametre
TR24653A (tr) Aciloksinitrojen perasit iptidai maddeler
BR8704087A (pt) Composicao
DE3688407T2 (de) Covulkanisierbare Zusammensetzungen von Fluorelastomeren.
LV5649A3 (lv) Herbicida kompozicija
RO95836A (ro) Compozitie erbicida lichida
DE3750642D1 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene.
RO96327A (ro) Compozitie nematocida si insecticida
FR2593392B1 (fr) Composition cosmetique
KR870000192U (ko) 인조 손톱
DK541487D0 (da) Sammenfoejning af materialer
DK289987A (da) Anvendelse af avaron- og avarolderivater
KR870018233U (ko) 상하 이동식 칠판
DK289887D0 (da) Anvendelse af avaron- og avarolderivater
ES1005243Y (es) Cierre esparcidor enterizo
DK554886A (da) Antistoffer
ES294660Y (es) Parasol
KR880002496U (ko) 인조장작
BR6601054U (pt) Mochila

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee